Today: 10 June 2026
Browse Category

Stock Market 29 May 2026

Gap Shares Stall After Old Navy Trouble Hits Traders

Gap Shares Stall After Old Navy Trouble Hits Traders

Gap shares fell 17.6% to $20.60 Friday after the company cut its full-year sales outlook, citing weak demand at Old Navy, especially in women’s dresses. Gap now expects 1% to 2% sales growth, down from 2% to 3%. The retailer raised its adjusted earnings forecast, but investors focused on slowing sales. Net sales rose 1% to $3.5 billion last quarter, with gross margin down to 40.5%.
29 May 2026
Replimune jumps 85% after FDA opens up third dose for skin cancer therapy

Replimune jumps 85% after FDA opens up third dose for skin cancer therapy

Replimune Group shares soared 85% to $8.64 Friday after the company said it will resubmit its advanced melanoma drug RP1 to the FDA, which agreed to a priority review. The FDA had rejected the therapy in April, citing lack of a control group. Replimune plans to file again within days and will present new trial data at an oncology meeting May 30. Bristol Myers fell 0.6%, while Iovance dropped 6.5%.
Rivian shares rise as company announces R2 SUV launch date

Rivian shares rise as company announces R2 SUV launch date

Rivian shares rose 7.6% to $16.36 by midday Friday after the company set June 9 for its first R2 SUV customer event. Trading volume reached 24.3 million shares. Rivian expects to deliver up to 25,000 R2s by year-end and reported $1.381 billion in first-quarter revenue. U.S. regulators opened a preliminary probe into 114,922 R1S and R1T vehicles over a possible suspension defect.
Tesla Shares Edge Down Despite New FSD Approval

Tesla Shares Edge Down Despite New FSD Approval

Tesla shares fell 1.2% to $436.86 Friday afternoon, lagging the S&P 500’s 0.4% gain, despite European approval for its Full Self-Driving software. Estonia cleared FSD for use, but regulators classified it as Level 2, requiring driver supervision. Tesla’s European registrations rose 46.5% in April, but BYD’s jumped 114.5%. The company raised its 2026 capital spending plan to over $25 billion, warning of negative free cash flow.
Vanguard VGT split points to the AI trade’s top play

Vanguard VGT split points to the AI trade’s top play

Vanguard’s Information Technology ETF (VGT) has nearly doubled the post-split returns of Vanguard’s larger growth funds since April 21. VGT’s top holdings—Nvidia, Apple, and Microsoft—make up over 40% of its portfolio. The ETF traded at $120.68 late Friday morning in New York, outpacing VUG at $89.51 and MGK at $91.16. Investors continue to buy into AI hardware and software plays.
Rocket Lab Surge Pauses as Space IPO Momentum Faces Wall

Rocket Lab Surge Pauses as Space IPO Momentum Faces Wall

Rocket Lab shares fell 6.5% to $138.37 by midday Friday, erasing part of this week’s rally. The drop followed a failed Blue Origin rocket test and reports SpaceX may target a lower IPO valuation. Rocket Lab cleared a key Space Development Agency review for its $816 million missile-warning satellite contract. The company also completed its acquisition of Motiv Space Systems.
CrowdStrike Moves Early in AI Trade Ahead of Earnings

CrowdStrike Moves Early in AI Trade Ahead of Earnings

CrowdStrike shares climbed 6.5% midday Friday to about $714.55, tracking gains across cybersecurity after Snowflake raised its revenue outlook and signed a $6 billion AWS deal. CrowdStrike is set to report fiscal Q1 2027 results after markets close June 3. The company’s stock is up 47.6% for the year. Analysts at Benchmark, Wedbush, and BTIG raised price targets this week.
IREN Shares Slide, Bringing Dell AI Deal and $4.4 Billion Test Into Focus

IREN Shares Slide, Bringing Dell AI Deal and $4.4 Billion Test Into Focus

IREN Limited shares fell 1.5% to $63.08 Friday, underperforming the Nasdaq-100. The company announced a $1.6 billion deal to buy Nvidia Blackwell systems from Dell, aiming to boost annualized revenue to $4.4 billion, though not all of that is under contract. IREN posted a Q3 net loss of $247.8 million as revenue dropped to $144.8 million. Goldman Sachs raised its price target to $50 but kept a Neutral rating.
3X AI Chip ETF surged from $100,000 to $1.28 million, but future gains get harder

3X AI Chip ETF surged from $100,000 to $1.28 million, but future gains get harder

Direxion Daily Semiconductor Bull 3X Shares (SOXL) traded just above $220 early Friday, down from a $224.63 close after a steep rally tied to AI chip demand. A $100,000 investment in SOXL a year ago would have grown to about $1.28 million by May 27, according to 24/7 Wall St. Nvidia posted record quarterly revenue of $81.6 billion, mostly from data centers. U.S. technology funds saw $2.75 billion in inflows last week.
Dell Technologies Stock Just Hit a Record. Wall Street Is Now Asking How Much AI Is Already Priced In

Dell stock catches Wall Street’s AI hardware attention

Dell shares jumped $87.50 to $404.55 Friday after the company raised its full-year outlook and reported quarterly revenue up 88% to $43.84 billion. AI-optimized server sales reached $16.1 billion, surpassing PC revenue. Dell booked $24.4 billion in AI orders and secured a $9.7 billion U.S. War Department contract. The company warned that rising memory costs and supply risks could pressure margins.
Micron (MU) stock falls 6% as oil shock rattles tech, even after new 256GB server-memory samples

Micron rises with AI memory but faces new push from Samsung

Micron shares jumped 4.6% to $966.24 Friday morning, lifting its market value above $1.1 trillion. The rally followed analyst price-target hikes and strong demand for high-bandwidth memory used in AI. Samsung shipped samples of its new HBM4E chips, introducing fresh competition in the AI memory market. Micron’s revenue in its latest quarter surged to $23.86 billion from $8.05 billion a year earlier.
HP Shares Jump on AI PC Demand, But Costs Are a Drag

HP Shares Jump on AI PC Demand, But Costs Are a Drag

HP shares rose to $26.98 in early New York trading Friday after the company beat quarterly revenue and profit forecasts, with AI PCs making up 44% of shipments last quarter. Fiscal Q2 net revenue climbed 9% to $14.4 billion, driven by a 13% jump in PC business revenue. HP cut its fiscal 2026 adjusted EPS outlook and warned of rising memory-chip costs. The stock outperformed major tech indexes.
ServiceNow AI move puts pressure on Salesforce

ServiceNow Stock Jumps as AI Deal Forces a Fresh Look at Growth Fears

ServiceNow shares jumped 9% Friday morning after announcing a partnership with Wipro, which will integrate its intelligence suite with the ServiceNow AI Platform. The stock reached $120 intraday before settling near $119. Wipro’s India-listed shares rose up to 4%, while its U.S. ADRs surged 19%. ServiceNow reported first-quarter subscription revenue of $3.67 billion, up 22% from a year earlier.
1 40 41 42 43 44 1,537

Stock Market Today

  • Copart (CPRT) Share Price Slump Raises Reassessment Questions Amid Undervaluation
    June 10, 2026, 8:50 AM EDT. Copart's share price has declined 37.7% over the past year, prompting investors to reassess its value. Recent trading closed at $31.31, a 1.5% rise over seven days but down 17.1% year to date. A Discounted Cash Flow (DCF) analysis estimates Copart's intrinsic value at $38.93, suggesting the stock is undervalued by approximately 19.6%. The DCF model, focusing on future free cash flow projections, indicates potential upside if cash flow assumptions hold. Copart trades at a Price-to-Earnings (P/E) ratio of 18.66, reflecting investor expectations on growth and risk. The prolonged multi-year price slump, coupled with evolving market perceptions in vehicle auction and salvage sectors, is driving fresh investor scrutiny on Copart's risk and growth potential.

Latest articles

Nuvalent Trades Close to $124 After GSK’s $10.6 Billion Offer

Nuvalent Trades Close to $124 After GSK’s $10.6 Billion Offer

10 June 2026
Nuvalent soared 39.28% to $123.25 after GSK agreed to buy the company for $124 per share in cash, leaving a narrow 0.6% spread as investors shift focus to the $10.6 billion merger’s tender-offer timing, antitrust review, and FDA decision dates for two lung-cancer drugs in September and November 2026.
IREN Stock Pauses as Nvidia Rally Cools Before Holiday

IREN Shares Fall Again; Microsoft AI Cloud Agreement Still in Focus

10 June 2026
IREN plunged 8.73% to $54.02 Tuesday and slid another 3.72% premarket as investors weighed Wall Street’s bullish calls on its AI cloud buildout against a tech and crypto selloff; the stock’s fate now hinges on IREN’s ability to deliver Microsoft- and Nvidia-linked AI infrastructure on schedule, with the Microsoft contract at risk if timelines slip.
Go toTop